Ipca Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?
IPCA LABS LTD has twenty-one approved drugs.
Drugs and US Patents for Ipca Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipca Labs Ltd | GABAPENTIN | gabapentin | CAPSULE;ORAL | 208928-003 | Nov 20, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 209389-001 | Oct 30, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-001 | Jun 27, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.